Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
University of Kansas
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dopamine-B-Hydroxylase in Human Cardiovascular Control
Medical School Pulmonary Faculty Training
Epidemiology of Germinal Matrix Hemorrhage
Ferroelectric Gradient Microfoams as High-Performance Self-Powered Flexible Pressure Sensors
Fault Modeling and Test Generation for Mixed-Signal Integrated Circuits
Recently added grants:
Dose Determination Trial for Implementing Evidence-Basedbehavioral Interventions
Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation
Genetic targeting of hippocampal CA2 pyramidal neurons
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075035-003
Application #
6688591
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
NIH 2002
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
Comments
Be the first to comment on this grant